InvestorsHub Logo
Followers 87
Posts 6676
Boards Moderated 1
Alias Born 09/18/2009

Re: dloggold post# 42843

Tuesday, 07/02/2024 8:41:37 PM

Tuesday, July 02, 2024 8:41:37 PM

Post# of 42856
No, I can't now, without doing a helluva lot of research on my old posts. But there are posters who still have search capability here, and it would be easier for one of them to find the posts in question.

Just a Google search found this.

https://www.wsj.com/articles/DJFVW00020121005e8a5mqn3m

So evidence of a partnership, which seems to have served its purpose.

"Sanofi

In January 2010, we entered into an agreement with Sanofi pursuant to which we granted to Sanofi an exclusive worldwide license to develop and commercialize KB001 (the precursor molecule to KB001-A), KB001-A and other antibodies directed against the PcrV protein of Pa for all indications but retained rights relating to Pa in patients with CF or bronchiectasis. In July 2014, we executed an agreement with Sanofi under which the Sanofi agreement was terminated."

see pg 14
https://www.sec.gov/Archives/edgar/data/1293310/000121465916013550/s82516010k.htm